Report Cover

Global and China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Insights, Forecast to 2027


Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
    Invokana (Canagliflozin)
    Jardiance (Empagliflozin)
    Farxiga/Forxiga (Dapagliflozin)
    Suglat (Ipragliflozin)

Segment by Application
    Hospital
    Medical Research Institute
    Other

By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        U.A.E

By Company
    Eli Lilly
    Janssen Pharmaceuticals
    Astellas
    Boehringer Ingelheim
    AstraZeneca
    Bristol Myers Squibb
    Kotobuki Pharmaceutical
1 Study Coverage
    1.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Introduction
    1.2 Market by Type
        1.2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Growth Rate by Type
        1.2.2 Invokana (Canagliflozin)
        1.2.3 Jardiance (Empagliflozin)
        1.2.4 Farxiga/Forxiga (Dapagliflozin)
        1.2.5 Suglat (Ipragliflozin)
    1.3 Market by Application
        1.3.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Growth Rate by Application
        1.3.2 Hospital
        1.3.3 Medical Research Institute
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Executive Summary
    2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, Estimates and Forecasts
        2.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue 2016-2027
        2.1.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales 2016-2027
    2.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors, Market Size by Region: 2016 VS 2021 VS 2027
    2.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Historical Market Size by Region (2016-2021)
        2.3.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Retrospective Market Scenario in Sales by Region: 2016-2021
        2.3.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Retrospective Market Scenario in Revenue by Region: 2016-2021
    2.4 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Estimates and Projections by Region (2022-2027)
        2.4.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Region (2022-2027)
        2.4.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Region (2022-2027)

3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Competitor Landscape by Players
    3.1 Global Top Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturers by Sales
        3.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Manufacturer (2016-2021)
        3.1.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Manufacturer (2016-2021)
    3.2 Global Top Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturers by Revenue
        3.2.1 Key Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturers Covered: Ranking by Revenue
        3.2.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Manufacturers (2016-2021)
        3.2.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Share by Manufacturers (2016-2021)
        3.2.4 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Concentration Ratio (CR5 and HHI) (2016-2021)
        3.2.5 Global Top 10 and Top 5 Companies by Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue in 2020
        3.2.6 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Manufacturers
    3.4 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturing Base Distribution, Product Types
        3.4.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Type
        3.4.3 Date of International Manufacturers Enter into Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
    4.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Type (2016-2021)
        4.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2016-2021)
        4.1.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Type (2016-2021)
        4.1.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Average Selling Price (ASP) by Type (2016-2021)
    4.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Forecast by Type (2022-2027)
        4.2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Type (2022-2027)
        4.2.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Type (2022-2027)
        4.2.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
    5.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Application (2016-2021)
        5.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2016-2021)
        5.1.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Application (2016-2021)
        5.1.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Application (2016-2021)
    5.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Forecast by Application (2022-2027)
        5.2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Application (2022-2027)
        5.2.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Application (2022-2027)
        5.2.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price Forecast by Application (2022-2027)

6 China by Players, Type and Application
    6.1 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size YoY Growth 2016-2027
        6.1.1 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales YoY Growth 2016-2027
        6.1.2 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue YoY Growth 2016-2027
        6.1.3 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share in Global Market 2016-2027
    6.2 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Players (International and Local Players)
        6.2.1 China Top Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Players by Sales (2016-2021)
        6.2.2 China Top Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Players by Revenue (2016-2021)
    6.3 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Historic Market Review by Type (2016-2021)
        6.3.1 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2016-2021)
        6.3.2 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Type (2016-2021)
        6.3.3 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Type (2016-2021)
    6.4 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Estimates and Forecasts by Type (2022-2027)
        6.4.1 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Type (2022-2027)
        6.4.2 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Type (2022-2027)
        6.4.3 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price Forecast by Type (2022-2027)
    6.5 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Historic Market Review by Application (2016-2021)
        6.5.1 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2016-2021)
        6.5.2 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Application (2016-2021)
        6.5.3 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Application (2016-2021)
    6.6 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Estimates and Forecasts by Application (2022-2027)
        6.6.1 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Application (2022-2027)
        6.6.2 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Application (2022-2027)
        6.6.3 China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price Forecast by Application (2022-2027)

7 North America
    7.1 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size YoY Growth 2016-2027
    7.2 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Facts & Figures by Country
        7.2.1 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2016-2021)
        7.2.2 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2016-2021)
        7.2.3 U.S.
        7.2.4 Canada

8 Asia Pacific
    8.1 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size YoY Growth 2016-2027
    8.2 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Facts & Figures by Region
        8.2.1 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region (2016-2021)
        8.2.2 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Region (2016-2021)
        8.2.3 China
        8.2.4 Japan
        8.2.5 South Korea
        8.2.6 India
        8.2.7 Australia
        8.2.8 Australia
        8.2.9 Indonesia
        8.2.10 Thailand
        8.2.11 Malaysia
        8.2.12 Philippines
        8.2.13 Vietnam

9 Europe
    9.1 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size YoY Growth 2016-2027
    9.2 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Facts & Figures by Country
        9.2.1 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2016-2021)
        9.2.2 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2016-2021)
        9.2.3 Germany
        9.2.4 France
        9.2.5 U.K.
        9.2.6 Italy

10 Latin America
    10.1 Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size YoY Growth 2016-2027
    10.2 Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Facts & Figures by Country
        10.2.1 Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2016-2021)
        10.2.2 Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2016-2021)
        10.2.3 Mexico
        10.2.4 Brazil
        10.2.5 Argentina

11 Middle East and Africa
    11.1 Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size YoY Growth 2016-2027
    11.2 Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Facts & Figures by Country
        11.2.1 Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2016-2021)
        11.2.2 Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2016-2021)
        11.2.3 Turkey
        11.2.4 Saudi Arabia
        11.2.5 U.A.E

12 Company Profiles
    12.1 Eli Lilly
        12.1.1 Eli Lilly Corporation Information
        12.1.2 Eli Lilly Description and Business Overview
        12.1.3 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
        12.1.5 Eli Lilly Recent Development
    12.2 Janssen Pharmaceuticals
        12.2.1 Janssen Pharmaceuticals Corporation Information
        12.2.2 Janssen Pharmaceuticals Description and Business Overview
        12.2.3 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
        12.2.5 Janssen Pharmaceuticals Recent Development
    12.3 Astellas
        12.3.1 Astellas Corporation Information
        12.3.2 Astellas Description and Business Overview
        12.3.3 Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
        12.3.5 Astellas Recent Development
    12.4 Boehringer Ingelheim
        12.4.1 Boehringer Ingelheim Corporation Information
        12.4.2 Boehringer Ingelheim Description and Business Overview
        12.4.3 Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
        12.4.5 Boehringer Ingelheim Recent Development
    12.5 AstraZeneca
        12.5.1 AstraZeneca Corporation Information
        12.5.2 AstraZeneca Description and Business Overview
        12.5.3 AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
        12.5.5 AstraZeneca Recent Development
    12.6 Bristol Myers Squibb
        12.6.1 Bristol Myers Squibb Corporation Information
        12.6.2 Bristol Myers Squibb Description and Business Overview
        12.6.3 Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
        12.6.5 Bristol Myers Squibb Recent Development
    12.7 Kotobuki Pharmaceutical
        12.7.1 Kotobuki Pharmaceutical Corporation Information
        12.7.2 Kotobuki Pharmaceutical Description and Business Overview
        12.7.3 Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
        12.7.5 Kotobuki Pharmaceutical Recent Development
    12.11 Eli Lilly
        12.11.1 Eli Lilly Corporation Information
        12.11.2 Eli Lilly Description and Business Overview
        12.11.3 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Products Offered
        12.11.5 Eli Lilly Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Trends
    13.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Drivers
    13.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Challenges
    13.4 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Restraints

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer

List of Tables Table 1. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Invokana (Canagliflozin) Table 3. Major Manufacturers of Jardiance (Empagliflozin) Table 4. Major Manufacturers of Farxiga/Forxiga (Dapagliflozin) Table 5. Major Manufacturers of Suglat (Ipragliflozin) Table 6. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Growth Rate by Application (2021-2027) & (Kg) Table 7. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Region (Kg) & (US$ Million), 2016 VS 2021 VS 2027 Table 8. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Regions (2016-2021) & (Kg) Table 9. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Regions (2016-2021) Table 10. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Regions (2016-2021) & (US$ Million) Table 11. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Region (2022-2027) & (Kg) Table 12. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share Forecast by Region (2022-2027) Table 13. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Region (2022-2027) & (US$ Million) Table 14. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share Forecast by Region (2022-2027) Table 15. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Manufacturers (2016-2021) (Kg) Table 16. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Manufacturers (2016-2021) Table 17. Ranking of Global Top Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturers by Revenue (US$ Million) in 2020 Table 18. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Manufacturers (2016-2021) (US$ Million) Table 19. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Share by Manufacturers (2016-2021) Table 20. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 21. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors as of 2020) Table 22. Key Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price (2016-2021) (USD/Kg) Table 23. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturers Manufacturing Base Distribution and Headquarters Table 24. Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Type Table 25. Date of International Manufacturers Enter into Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans Table 27. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2016-2021) (Kg) Table 28. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Type (2016-2021) Table 29. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Type (2016-2021) (US$ Million) Table 30. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Share by Type (2016-2021) Table 31. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Average Selling Price (ASP) by Type (2016-2021) & (USD/Kg) Table 32. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Type (2022-2027) & (Kg) Table 33. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share Forecast by Type (2022-2027) Table 34. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast V (2022-2027) & (US$ Million) Table 35. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share Forecast by Type (2022-2027) Table 36. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Kg) Table 37. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2016-2021) (Kg) Table 38. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Application (2016-2021) Table 39. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Application (2016-2021) (US$ Million) Table 40. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Share by Application (2016-2021) Table 41. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Average Selling Price (ASP) by Application (2016-2021) & (USD/Kg) Table 42. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Application (2022-2027) & (Kg) Table 43. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share Forecast by Application (2022-2027) Table 44. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Application (2022-2027) & (US$ Million) Table 45. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share Forecast by Application (2022-2027) Table 46. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Kg) Table 47. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg) of Key Companies (2016-2021) Table 48. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Company (2016-2021) Table 49. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (US$ Million) by Company (2016-2021) Table 50. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Share by Company (2016-2021) Table 51. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg) by Type (2016-2021) Table 52. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Type (2016-2021) Table 53. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (US$ Million) Market Share by Type (2016-2021) Table 54. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price (USD/Kg) by Type (2016-2021) Table 55. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg) by Type (2022-2027) Table 56. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Type (2022-2027) Table 57. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (US$ Million) Market Share by Type (2022-2027) Table 58. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Share by Type (2022-2027) Table 59. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price (USD/Kg) by Type (2022-2027) Table 60. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg) by Application (2016-2021) Table 61. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Application (2016-2021) Table 62. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (US$ Million) Market Share by Application (2016-2021) Table 63. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price (USD/Kg) by Application (2016-2021) Table 64. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg) by Application (2022-2027) Table 65. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Application (2022-2027) Table 66. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue (US$ Million) Market Share by Application (2022-2027) Table 67. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Share by Application (2022-2027) Table 68. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price (USD/Kg) by Application (2022-2027) Table 69. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2016-2021) & (Kg) Table 70. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country (2016-2021) Table 71. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2016-2021) & (US$ Million) Table 72. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country (2016-2021) Table 73. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Region (2016-2021) & (Kg) Table 74. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Region (2016-2021) Table 75. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Region (2016-2021) & (US$ Million) Table 76. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Region (2016-2021) Table 77. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2016-2021) & (Kg) Table 78. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country (2016-2021) Table 79. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2016-2021) & (US$ Million) Table 80. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country (2016-2021) Table 81. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2016-2021) & (Kg) Table 82. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country (2016-2021) Table 83. Latin Americaa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2016-2021) & (US$ Million) Table 84. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country (2016-2021) Table 85. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Country (2016-2021) & (Kg) Table 86. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country (2016-2021) Table 87. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Country (2016-2021) & (US$ Million) Table 88. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country (2016-2021) Table 89. Eli Lilly Corporation Information Table 90. Eli Lilly Description and Business Overview Table 91. Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 92. Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Table 93. Eli Lilly Recent Development Table 94. Janssen Pharmaceuticals Corporation Information Table 95. Janssen Pharmaceuticals Description and Business Overview Table 96. Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 97. Janssen Pharmaceuticals Product Table 98. Janssen Pharmaceuticals Recent Development Table 99. Astellas Corporation Information Table 100. Astellas Description and Business Overview Table 101. Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 102. Astellas Product Table 103. Astellas Recent Development Table 104. Boehringer Ingelheim Corporation Information Table 105. Boehringer Ingelheim Description and Business Overview Table 106. Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 107. Boehringer Ingelheim Product Table 108. Boehringer Ingelheim Recent Development Table 109. AstraZeneca Corporation Information Table 110. AstraZeneca Description and Business Overview Table 111. AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 112. AstraZeneca Product Table 113. AstraZeneca Recent Development Table 114. Bristol Myers Squibb Corporation Information Table 115. Bristol Myers Squibb Description and Business Overview Table 116. Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 117. Bristol Myers Squibb Product Table 118. Bristol Myers Squibb Recent Development Table 119. Kotobuki Pharmaceutical Corporation Information Table 120. Kotobuki Pharmaceutical Description and Business Overview Table 121. Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 122. Kotobuki Pharmaceutical Product Table 123. Kotobuki Pharmaceutical Recent Development Table 124. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Trends Table 125. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Drivers Table 126. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Challenges Table 127. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Restraints Table 128. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Customers List Table 129. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Distributors List Table 130. Research Programs/Design for This Report Table 131. Key Data Information from Secondary Sources Table 132. Key Data Information from Primary Sources List of Figures Figure 1. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Picture Figure 2. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type in 2020 & 2027 Figure 3. Invokana (Canagliflozin) Product Picture Figure 4. Jardiance (Empagliflozin) Product Picture Figure 5. Farxiga/Forxiga (Dapagliflozin) Product Picture Figure 6. Suglat (Ipragliflozin) Product Picture Figure 7. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application in 2020 & 2027 Figure 8. Hospital Figure 9. Medical Research Institute Figure 10. Other Figure 11. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Report Years Considered Figure 12. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size 2016-2027 (US$ Million) Figure 14. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales 2016-2027 (Kg) Figure 15. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Market Share by Region: 2021 Versus 2027 Figure 16. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Region (2016-2021) Figure 17. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Region in 2020 Figure 18. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Region (2016-2021) Figure 19. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Region in 2020 Figure 20. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Manufacturer in 2020 Figure 21. The Top 10 and 5 Players Market Share by Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue in 2020 Figure 22. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 23. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2016-2021) Figure 24. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type in 2020 Figure 25. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Type (2016-2021) Figure 26. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Type in 2020 Figure 27. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2016-2021) Figure 28. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application in 2020 Figure 29. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Application (2016-2021) Figure 30. Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Application in 2020 Figure 31. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate 2016-2027 (Kg) Figure 32. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate 2016-2027 (US$ Million) Figure 33. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share in Global Market 2016-2027 Figure 34. China 5 and 10 Largest Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Players Market Share by Revenue in Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors in 2020 Figure 35. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Share by Type (2016-2021) Figure 36. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate by Type in 2016 & 2020 Figure 37. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Share by Application (2016-2021) Figure 38. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate by Application in 2016 & 2020 Figure 39. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate 2016-2021 (Kg) Figure 40. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate 2016-2021 (US$ Million) Figure 41. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country in 2020 Figure 42. North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country in 2020 Figure 43. U.S. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2016-2021) (Kg) Figure 44. U.S. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Canada Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2016-2021) (Kg) Figure 46. Canada Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate 2016-2021 (Kg) Figure 48. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate 2016-2021 (US$ Million) Figure 49. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country in 2020 Figure 50. Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country in 2020 Figure 51. Germany Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2016-2021) (Kg) Figure 52. Germany Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 53. France Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2016-2021) (Kg) Figure 54. France Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 55. U.K. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2016-2021) (Kg) Figure 56. U.K. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 57. Italy Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2016-2021) (Kg) Figure 58. Italy Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. Russia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2016-2021) (Kg) Figure 60. Russia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 61. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate 2016-2021 (Kg) Figure 62. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate 2016-2021 (US$ Million) Figure 63. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Region in 2020 Figure 64. Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Region in 2020 Figure 65. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2016-2021) (Kg) Figure 66. China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 67. Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2016-2021) (Kg) Figure 68. Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 69. South Korea Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2016-2021) (Kg) Figure 70. South Korea Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 71. India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2016-2021) (Kg) Figure 72. India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. Australia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2016-2021) (Kg) Figure 74. Australia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. Taiwan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2016-2021) (Kg) Figure 76. Taiwan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. Indonesia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2016-2021) (Kg) Figure 78. Indonesia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Thailand Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2016-2021) (Kg) Figure 80. Thailand Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Malaysia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2016-2021) (Kg) Figure 82. Malaysia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Philippines Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2016-2021) (Kg) Figure 84. Philippines Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 85. Vietnam Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2016-2021) (Kg) Figure 86. Vietnam Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 87. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate 2016-2021 (Kg) Figure 88. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate 2016-2021 (US$ Million) Figure 89. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country in 2020 Figure 90. Latin America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country in 2020 Figure 91. Mexico Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2016-2021) (Kg) Figure 92. Mexico Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 93. Brazil Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2016-2021) (Kg) Figure 94. Brazil Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 95. Argentina Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2016-2021) (Kg) Figure 96. Argentina Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 97. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate 2016-2021 (Kg) Figure 98. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate 2016-2021 (US$ Million) Figure 99. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Country in 2020 Figure 100. Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Country in 2020 Figure 101. Turkey Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2016-2021) (Kg) Figure 102. Turkey Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 103. Saudi Arabia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2016-2021) (Kg) Figure 104. Saudi Arabia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 105. U.A.E Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2016-2021) (Kg) Figure 106. U.A.E Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 107. Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Value Chain Figure 108. Channels of Distribution Figure 109. Distributors Profiles Figure 110. Bottom-up and Top-down Approaches for This Report Figure 111. Data Triangulation Figure 112. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us